Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1574, 2007-01, pp. : 1-1
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Ezetimibe may lead to paradoxical progression of atherosclerosis
Reactions Weekly, Vol. 1, Iss. 1406, 2012-01 ,pp. :
PPAR activation may limit inflammation and atherosclerosis
Inpharma, Vol. 1, Iss. 1411, 2003-01 ,pp. :
Cardiovascular benefits from statin therapy may be mediated by anti-inflammatory effects
Inpharma, Vol. 1, Iss. 1391, 2003-01 ,pp. :